Related Experiment Videos
Do we need more drugs to treat Parkinson's disease?
W J Weiner1, L M Shulman, W H Oertel
1Department of Neurology, University of Miami School of Medicine, Florida, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson's disease.
NPJ Parkinson's disease·2024
Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease.
Parkinsonism & related disorders·2022
The inconsistency and instability of Parkinson's disease motor subtypes.
Parkinsonism & related disorders·2021
Consistent skin α-synuclein positivity in REM sleep behavior disorder - A two center two-to-four-year follow-up study.
Parkinsonism & related disorders·2021
[The role of the gut microbiome in idiopathic Parkinson's disease].
Der Nervenarzt·2020
Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility.
European journal of neurology·2019
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling.
American journal of physiology. Heart and circulatory physiology·2026
Postbiotic Metabolites: Therapeutic Potential, Industrial Applications, Market Dynamics, and Regulatory Frameworks.
Probiotics and antimicrobial proteins·2026